Ingestible Capsules: Future of GI Diagnostics and Drug Delivery
In this episode of MedDevice by Design, Mark Drlik and Ariana Wilson introduce the fascinating world of ingestible capsules—tiny, swallowable medical devices that are revolutionizing gastrointestinal health monitoring and targeted therapy.
What Are Ingestible Capsules?
Ingestible capsules are advanced devices designed to be swallowed and travel through the gastrointestinal tract. Originally developed for imaging purposes, they have evolved to support functions like microbiome sampling, localized drug delivery, and even systemic therapies.
The early pioneers, like Given Imaging, brought capsule endoscopy into clinical use. More than a million people have used these capsules to detect bleeding or abnormalities in the stomach and intestines. Today, innovations allow some capsules to autonomously identify their location using onboard sensors and light reflection, removing the need for external imaging like CT or ultrasound.
Key Innovations and Use Cases
Mark explains how newer capsules can:
- Autonomously identify their position in the GI tract
- Collect biological samples from specific regions
- Deliver drugs to targeted locations
- Break through intestinal walls to deliver systemic treatments
This growing technology is gaining traction for its ability to interact with the complex and previously hard-to-reach environment of the gut.
Development Challenges
Packing motors, batteries, and sensors into a capsule measuring just 11.6 mm by 26 mm is no small feat. Mark compares its computing power to his old Nintendo, showcasing how much performance engineers now fit into a swallowable form factor.
Looking Ahead
The future of ingestible capsules includes more accurate positioning systems, longer battery life, and expanded use in diagnostics, treatment, and monitoring. This episode highlights the ingenuity behind these devices and the opportunities they offer in transforming patient care.
Enjoying MedDevice by Design? Sign up to get new episodes sent to your inbox.
Related Resources
Nick Allan and Nigel Syrotuck explain exactly how aminoglycoside antibiotics work and why they’re so effective at killing bacteria.
Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.
Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.
Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.